Home / Stocks / VRDN

VRDN insider trading

Viridian Therapeutics, Inc.\DE — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$60.6M
Buys · last 90 days
0 · $0
Most recent buy
2026-05-13

Cluster buy detected

3 insiders bought VRDN within a short window (2024-09-13→2024-09-27), $30.6M in total — cluster score 77/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-13Fairmount Funds Management LLC
Director · 10% owner
Bought1,176,470$17.00$20.0M
2025-10-27Fairmount Funds Management LLC
Director · 10% owner
Bought454,545$22.00$10.0M
2024-09-30Beetham Thomas W.cluster
Chief Operating Officer
Bought5,000$23.41$117k
2024-09-30Mahoney Stephen F.cluster
President and CEO
Bought21,400$23.33$499k
2024-09-17Fairmount Funds Management LLCcluster
Director · 10% owner
Bought1,600,000$18.75$30.0M

Most active insider buyers

InsiderRoleBuysTotal bought
Fairmount Funds Management LLCDirector · 10% owner3$60.0M
Mahoney Stephen F.President and CEO1$499k
Beetham Thomas W.Chief Operating Officer1$117k

See VRDN on the chart

Every insider buy and sell for VRDN plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.